Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-02-22 @ 5:57 PM
Study NCT ID:
NCT04249167
Status:
WITHDRAWN
Last Update Posted:
2023-01-06
First Post:
2020-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anatomic Stage III Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIA Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIB Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IIIC Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IV Breast Cancer AJCC v8 | View |
| None | Locally Advanced Breast Carcinoma | View |
| None | Metastatic Triple-Negative Breast Carcinoma | View |
| None | Prognostic Stage III Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIA Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIB Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IIIC Breast Cancer AJCC v8 | View |
| None | Prognostic Stage IV Breast Cancer AJCC v8 | View |
Keywords: